Cytokinetics Inc (CYTK)
48.53
-0.42
(-0.86%)
USD |
NASDAQ |
Dec 24, 16:00
Cytokinetics Cash from Investing (Quarterly): -45.05M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Insmed Inc | -1.003B |
| Rezolute Inc | -49.41M |
| Ocugen Inc | -0.507M |
| Scholar Rock Holding Corp | 35.31M |
| Mirum Pharmaceuticals Inc | -18.04M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -101.50M |
| Cash from Financing (Quarterly) | 3.425M |
| Free Cash Flow | -407.05M |
| Free Cash Flow Per Share (Quarterly) | -0.8684 |
| Free Cash Flow to Equity (Quarterly) | -103.27M |
| Free Cash Flow Yield | -7.84% |